These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29344328)

  • 21. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
    Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
    Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting and postprandial gastric sensorimotor activity in functional dyspepsia: postprandial distress vs. epigastric pain syndrome.
    Di Stefano M; Miceli E; Tana P; Mengoli C; Bergonzi M; Pagani E; Corazza GR
    Am J Gastroenterol; 2014 Oct; 109(10):1631-9. PubMed ID: 25199472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia.
    Tack J; Janssen P
    Expert Opin Investig Drugs; 2011 May; 20(5):701-12. PubMed ID: 21417958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification.
    Vakil N; Halling K; Ohlsson L; Wernersson B
    Am J Gastroenterol; 2013 May; 108(5):767-74. PubMed ID: 23567354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: treatment options for functional dyspepsia.
    Masuy I; Van Oudenhove L; Tack J
    Aliment Pharmacol Ther; 2019 May; 49(9):1134-1172. PubMed ID: 30924176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Functional dyspepsia: the past, the present and the Rome III classification].
    Buzás GM
    Orv Hetil; 2007 Aug; 148(33):1573-9. PubMed ID: 17686677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind randomized, multicenter, placebo-controlled study of itopride in functional dyspepsia postprandial distress syndrome.
    Carbone F; Vandenberghe A; Holvoet L; Piessevaux H; Arts J; Caenepeel P; Staessen D; Vergauwe P; Maldague P; De Ronde T; Wuestenberghs F; Lamy V; Lefebvre V; Latour P; Vanuytsel T; Jones M; Tack J
    Neurogastroenterol Motil; 2022 Aug; 34(8):e14337. PubMed ID: 35357058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
    Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
    Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging drugs for functional dyspepsia.
    Zala AV; Walker MM; Talley NJ
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):221-33. PubMed ID: 25645940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of sleep disorders, quality of life and gastric emptying in distinct subtypes of functional dyspepsia in Japan.
    Yamawaki H; Futagami S; Shimpuku M; Sato H; Wakabayashi T; Maruki Y; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Neurogastroenterol Motil; 2014 Jan; 20(1):104-12. PubMed ID: 24466451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New developments in the treatment of functional dyspepsia.
    Stanghellini V; De Ponti F; De Giorgio R; Barbara G; Tosetti C; Corinaldesi R
    Drugs; 2003; 63(9):869-92. PubMed ID: 12678573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acotiamide and Functional Dyspepsia: A Systematic Review and Meta-Analysis.
    Shrestha DB; Budhathoki P; Subedi P; Khadka M; Karki P; Sedhai YR; Karki BR; Mir WAY
    Cureus; 2021 Dec; 13(12):e20532. PubMed ID: 35070565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton-pump inhibitors for the treatment of functional dyspepsia.
    Suzuki H; Okada S; Hibi T
    Therap Adv Gastroenterol; 2011 Jul; 4(4):219-26. PubMed ID: 21765866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats.
    Kawachi M; Matsunaga Y; Tanaka T; Hori Y; Ito K; Nagahama K; Ozaki T; Inoue N; Toda R; Yoshii K; Hirayama M; Kawabata Y; Takei M
    Eur J Pharmacol; 2011 Sep; 666(1-3):218-25. PubMed ID: 21651906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acotiamide: first global approval.
    Nowlan ML; Scott LJ
    Drugs; 2013 Aug; 73(12):1377-83. PubMed ID: 23881665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gastrin secretion in patients with functional dyspepsia].
    Walecka-Kapica E; Klupińska G; Stec-Michalska K; Olszowiec K; Pawłowicz M; Chojnacki C
    Pol Merkur Lekarski; 2009 May; 26(155):362-5. PubMed ID: 19606674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Approaches to Diagnosis and Treatment of Functional Dyspepsia.
    Tomita T; Oshima T; Miwa H
    Curr Gastroenterol Rep; 2018 Oct; 20(12):55. PubMed ID: 30338390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acotiamide Hydrochloride, a Therapeutic Agent for Functional Dyspepsia, Enhances Acetylcholine-induced Contraction via Inhibition of Acetylcholinesterase Activity in Circular Muscle Strips of Guinea Pig Stomach.
    Ito K; Kawachi M; Matsunaga Y; Hori Y; Ozaki T; Nagahama K; Hirayama M; Kawabata Y; Shiraishi Y; Takei M; Tanaka T
    Drug Res (Stuttg); 2016 Apr; 66(4):196-202. PubMed ID: 26418413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acotiamide affects antral motility, but has no effect on fundic motility, gastric emptying or symptom perception in healthy participants.
    Masuy I; Tack J; Verbeke K; Carbone F
    Neurogastroenterol Motil; 2019 Apr; 31(4):e13540. PubMed ID: 30663175
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.